FI952803A0 - Bensazepinonderivat - Google Patents

Bensazepinonderivat

Info

Publication number
FI952803A0
FI952803A0 FI952803A FI952803A FI952803A0 FI 952803 A0 FI952803 A0 FI 952803A0 FI 952803 A FI952803 A FI 952803A FI 952803 A FI952803 A FI 952803A FI 952803 A0 FI952803 A0 FI 952803A0
Authority
FI
Finland
Prior art keywords
benzazepinone derivatives
benzazepinone
derivatives
Prior art date
Application number
FI952803A
Other languages
English (en)
Finnish (fi)
Other versions
FI952803A (sv
Inventor
Peter Buehlmayer
Pascal Furet
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI952803A publication Critical patent/FI952803A/sv
Publication of FI952803A0 publication Critical patent/FI952803A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI952803A 1992-12-11 1995-06-07 Bensazepinonderivat FI952803A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH380192 1992-12-11
PCT/EP1993/003426 WO1994013651A1 (de) 1992-12-11 1993-12-06 Benzazepinon-derivate

Publications (2)

Publication Number Publication Date
FI952803A FI952803A (sv) 1995-06-07
FI952803A0 true FI952803A0 (sv) 1995-06-07

Family

ID=4263742

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952803A FI952803A0 (sv) 1992-12-11 1995-06-07 Bensazepinonderivat

Country Status (11)

Country Link
US (1) US5610153A (sv)
EP (1) EP0673371A1 (sv)
JP (1) JPH08505374A (sv)
KR (1) KR950704280A (sv)
AU (1) AU685768B2 (sv)
CA (1) CA2151384A1 (sv)
FI (1) FI952803A0 (sv)
HU (1) HUT72330A (sv)
NO (1) NO952288D0 (sv)
NZ (1) NZ258889A (sv)
WO (1) WO1994013651A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines
WO1996040656A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
ATE354364T1 (de) 1998-12-23 2007-03-15 Novartis Pharma Gmbh Verwendung von at-1 rezeptorantagonisten oder at- 2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
US6211217B1 (en) 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
GB9914745D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US7291639B2 (en) * 2001-06-20 2007-11-06 Wyeth Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
KR100710547B1 (ko) * 2002-01-02 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
KR100710548B1 (ko) 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
WO2019246541A1 (en) * 2018-06-21 2019-12-26 Dana-Farber Cancer Institute, Inc. Inhibitors of egfr and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269625D1 (en) * 1981-08-11 1986-04-10 Ciba Geigy Ag Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0673371A1 (de) 1995-09-27
FI952803A (sv) 1995-06-07
US5610153A (en) 1997-03-11
CA2151384A1 (en) 1994-06-23
NZ258889A (en) 1997-02-24
JPH08505374A (ja) 1996-06-11
HU9501693D0 (en) 1995-08-28
HUT72330A (en) 1996-04-29
NO952288L (no) 1995-06-09
WO1994013651A1 (de) 1994-06-23
NO952288D0 (no) 1995-06-09
KR950704280A (ko) 1995-11-17
AU5696794A (en) 1994-07-04
AU685768B2 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
ATA75293A (de) Indolderivate
DE69332540D1 (de) Rapamycinderivate
DE69332484D1 (de) Rapamycinderivate
DE69330497D1 (de) Chinazolin-derivate
DE69332582D1 (de) Rapamycinderivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI931121A0 (fi) Bockningspress foer framstaellning av boejda glasrutor
NO930520D0 (no) Bifenyl-substituerte kinolinderivater
FI952803A0 (sv) Bensazepinonderivat
DE69313890D1 (de) 5-Aminoflavon-Derivate
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
NO924543D0 (no) Maktocykliske laktamderivater
FI930710A (fi) Anordning foer oevervakning av vaetskenivao
FI532U1 (fi) Vaetskeavskiljningsventil foer sprutroeret av en pappers- eller kartongmaskin
FI920011A (fi) Av roerformade delar bildat vaeggelement
DE69308414D1 (de) Monensinderivate
FI934756A0 (fi) Anordning foer avlaegsnande av utstansade delar
DE69400388D1 (de) Cyclohexendiolderivate
BR9306706A (pt) Derivados do triazolil-butano
FI921441A (fi) Anordning foer framstaellning av en spaelgardin
NO940360D0 (no) Heterocykliske derivater
FI21U1 (fi) Anordning foer uppskattning av avstaond
FI240U1 (fi) Skyddsrum av betongelement
FI62U1 (fi) Anordning foer emballering av varor
FI164U1 (fi) Traeningskaerra foer traening av travhaest

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed